[Cancer of the kidney in adults. Treatment of the metastatic stage].
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy / Q000473:pathology / Q000556:secondary* / Q000601:surgery / Q000628:therapy; D003131:Combined Modality Therapy; D006304:Health Status; D006801:Humans; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000628:therapy*; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D009392:Nephrectomy; D010166:Palliative Care; D011379:Prognosis; D015996:Survival Rate; D015431:Weight Loss
D018931:Antineoplastic Agents, Hormonal; D007376:Interleukin-2; D007372:Interferons
Cancer du rein de l'adulte. Traitement au stade métastatique.